Member Info for Sangijuelas1

Rome wasn't built in a day

Psb you should be able to use the link below. If not available now it will be in the next few days

It sounded like one detailed interim update on 0518 Keytruda with possibly another in 2022.

Asthma within the next month

Pancreatic cancer with 0518 /radiotherapy towards the end of the year

Announcement around Blautix plans by the end of the year. Said still talking to potential partners who they could out licence to

It sounds like they want any additional releases to include the biomarker analysis so they would be replicating both the amount of patients it worked in and why it worked in them based on the tumour biomarkers

Alex fielded questions very well. Very calm with concise and confident explanations

Suggested that they might keep oncology in house and licence out for IBS and asthma

Questions about the ESMO news about being able to identify patients resistant to immune checkpoint inhibitors

Can expect data from 0518 before the end of the year as they want it to be more comprehensive picture rather than a snapshot

Question about single strain approach and differentiation with other microbiome companies

Better demonstration of functionality and ability to isolate most effective single strains

Easier to manufacture single strain and keep production in house

Importance of having manufacturing plant and the experience they have accumulated

Patents apply to processes across development and manufacturing and not just the strains themselves

Will shortly be reporting on the asthma trial

Just running through presentation. Confirmed that vaccine collaboration with MSD still ongoing, which is good to hear

If he had combed his hair it would mean they had found cure for baldness

How about a 4D/Angle merger? Angle could pay for the ongoing trials with the labs contract income

I imagine it will just be a quick run through for potential new US investors, gonna catch it all the same

See if DP has put a tie on!

Oppenheimer in just under an hour
https://www.4dpharmaplc.com/en/newsroom/events

Seller does seem to have slowed down somewhat. Just got the bots with the auto sells stopping it from breaking 70

Tightened up a bit now. Made me think MMs not expecting the high volumes the seller generates.

Hasn't been wide as this for a while.

As a 4D Pharma investor can instantly understand the pharma trial need for Parsortix. This could definitely be used in their MRx0518 trials with Pembro and Bavencio.

It's really important to be able to identify likely responders to ICIs.

I hope 4D have their eye on Parsortix

It's not. You often do get an RNS after one. But not always the one you want. Often been in ones where the 1 trade comes in and after 4.30 you get an RNS about some staff taking up a few thousand options.

There was one the day before we got the ESMO RNS.

Like I said it could just turn out to be a holdings Rns for Oliveira but they do have the Oppenheimer event tomorrow so would be good time to release earth shattering news on the 0518 progress